Distinct chromatin binding patterns for estrogen receptor and histone marks classify aromatase inhibitor resistant breast cancer

被引:0
|
作者
Jansen, M. [1 ]
Knijnenburg, T. [2 ]
Reijm, E. [3 ]
Simon, I. [4 ]
Kerkhoven, R. [5 ]
Alexi, X. [2 ]
Wessels, L. [2 ]
Linn, S. [2 ]
Berns, P. [3 ]
Zwart, W. [2 ]
机构
[1] Erasmus MC Univ, Med Ctr Rotterdam, Rotterdam, Netherlands
[2] Netherlands Canc Inst, Amsterdam, Netherlands
[3] Erasmus MC Univ, Med Ctr, Rotterdam, Netherlands
[4] Agendia, Amsterdam, Netherlands
[5] Netherlands Canc Inst, Cent Genom Facil, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
500
引用
收藏
页码:S97 / S97
页数:1
相关论文
共 50 条
  • [1] Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer
    Makhlin, Igor
    McAndrew, Nicholas P.
    Wileyto, E. Paul
    Clark, Amy S.
    Holmes, Robin
    Bottalico, Lisa N.
    Mesaros, Clementina
    Blair, Ian A.
    Jeschke, Grace R.
    Fox, Kevin R.
    Domchek, Susan M.
    Matro, Jennifer M.
    Bradbury, Angela R.
    Feldman, Michael D.
    Hexner, Elizabeth O.
    Bromberg, Jacqueline F.
    DeMichele, Angela
    NPJ BREAST CANCER, 2022, 8 (01)
  • [2] Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer
    Igor Makhlin
    Nicholas P. McAndrew
    E. Paul Wileyto
    Amy S. Clark
    Robin Holmes
    Lisa N. Bottalico
    Clementina Mesaros
    Ian A. Blair
    Grace R. Jeschke
    Kevin R. Fox
    Susan M. Domchek
    Jennifer M. Matro
    Angela R. Bradbury
    Michael D. Feldman
    Elizabeth O. Hexner
    Jacqueline F. Bromberg
    Angela DeMichele
    npj Breast Cancer, 8
  • [3] Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
    Lui, Asona
    New, Jacob
    Ogony, Joshua
    Thomas, Sufi
    Lewis-Wambi, Joan
    BMC CANCER, 2016, 16
  • [4] Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
    Asona Lui
    Jacob New
    Joshua Ogony
    Sufi Thomas
    Joan Lewis-Wambi
    BMC Cancer, 16
  • [5] Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
    Swaathi Jayaraman
    Xiaonan Hou
    Mary J. Kuffel
    Vera J. Suman
    Tanya L. Hoskin
    Kathryn E. Reinicke
    David G. Monroe
    Krishna R. Kalari
    Xiaojia Tang
    Megan A. Zeldenrust
    Jingfei Cheng
    Elizabeth S. Bruinsma
    Sarah A. Buhrow
    Renee M. McGovern
    Stephanie L. Safgren
    Chad A. Walden
    Jodi M. Carter
    Joel M. Reid
    James N. Ingle
    Matthew M. Ames
    John R. Hawse
    Matthew P. Goetz
    Breast Cancer Research, 22
  • [6] Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
    Jayaraman, Swaathi
    Hou, Xiaonan
    Kuffel, Mary J.
    Suman, Vera J.
    Hoskin, Tanya L.
    Reinicke, Kathryn E.
    Monroe, David G.
    Kalari, Krishna R.
    Tang, Xiaojia
    Zeldenrust, Megan A.
    Cheng, Jingfei
    Bruinsma, Elizabeth S.
    Buhrow, Sarah A.
    McGovern, Renee M.
    Safgren, Stephanie L.
    Walden, Chad A.
    Carter, Jodi M.
    Reid, Joel M.
    Ingle, James N.
    Ames, Matthew M.
    Hawse, John R.
    Goetz, Matthew P.
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [7] Investigation into the oncogenic potential of the androgen receptor in aromatase inhibitor resistant breast cancer
    Young, Leonie
    Creevey, Laura
    Ali, Azlena
    Hill, Arnold D. K.
    McIlroy, Marie
    CANCER RESEARCH, 2015, 75
  • [8] The impact of circulating androgens on the androgen receptor in aromatase inhibitor resistant breast cancer
    Creevey, L.
    Ali, A.
    Bleach, R.
    Hill, A. D. K.
    Young, L.
    McIlroy, M.
    CANCER RESEARCH, 2017, 77
  • [9] Extending aromatase inhibitor sensitivity in hormone resistant breast cancer
    Brodie, Angela M. H.
    Chumsri, Saranya
    Sukumar, Sara
    Sabnis, Gauri J.
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2011, 5 (02) : 97 - 103
  • [10] Characterising an aromatase inhibitor resistant breast cancer cell line
    E Harris
    D Varešlija
    J O'Hara
    A Hill
    L Young
    BMC Proceedings, 6 (Suppl 4)